Human single‐chain urokinase‐type plasminogen activator without an N‐glycosylation site (scu‐PA‐Q302) was produced in the methylotrophic yeast, Pichia pastoris using the shortened prepeptide sequence of a fungal aspartic proteinase, Mucor pusillus rennin (MPR). The level of urokinase‐type plasminogen activator (u‐PA) immunoreactive material in YPM medium was 0·47 mg/l; however, most of the secreted product had been processed to smaller polypeptides. The N‐terminal amino acid sequence of major species was identical to that of the low molecular weight two‐chain u‐PA. Some approaches to minimizing the proteolysis of scu‐PA‐Q302 were attempted. Addition of Triton X‐100, l‐arginine and ammonium phosphate to the YPM medium minimized the proteolysis of scu‐PA‐Q302 and increased the yield of immunoreactive material to approximately 5 mg/l. Use of proteinase A‐ or proteinase B‐deficient strains of yeast did not reduce the degradation. Co‐expression of scu‐PA‐Q302 and urinary trypsin inhibitor resulted in partial reduction of the major species of proteolysis.
Scu‐PA‐Q302 was purified from the culture supernatant of the improved medium by two successive chromatographies on Phenyl‐Sepharose and S‐Sepharose. The purified protein had a molecular weight of 47 kDa. It did not contain detectable N‐linked oligosaccharides, but contained O‐linked oligosaccharides attached to the light chain. N‐terminal amino acid sequencing of the purified preparation showed that the shortened prepeptide sequence of MPR was correctly processed by the Pichia yeast. Scu‐PA‐Q302 closely resembles natural scu‐PA with respect to its enzymatic activity against the chromogenic substrate S‐2444 and its in vitro fibrinolytic properties.